• Structure Therapeutics Chief Scientific Officer Lin Xichen cut direct ordinary share holdings to 228,960 on July 14.
• Lin exercised options for 23,634 ordinary shares at $0.34 per share, then converted those shares into 7,878 American Depositary Shares.
• Lin sold 7,878 American Depositary Shares at weighted average prices of $50.8 and $51.71 under a Rule 10b5-1 plan.
• Lin ended the day with 1,600 American Depositary Shares, down from 7,878.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Structure Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001962926-26-000006), on July 15, 2026, and is solely responsible for the information contained therein.